GeneDx Names Partners for Epilepsy Diagnostic Program
GeneDx named the partners of its Patient Access Program that provides whole exome sequencing for pediatric epilepsy.
Read MorePosted by Andy Lundin | Dec 5, 2024 | Molecular Diagnostics |
GeneDx named the partners of its Patient Access Program that provides whole exome sequencing for pediatric epilepsy.
Read MorePosted by Andy Lundin | Dec 5, 2024 | Cancer |
Function Health will offer GRAIL’s Galleri multi-cancer early detection test, empowering proactive cancer care through a simple blood draw.
Read MorePosted by Andy Lundin | Dec 4, 2024 | Sequencing Systems |
Delve Bio’s Delve Detect is a metagenomic sequencing test capable of quickly identifying over 68,000 pathogens from CSF.
Read MorePosted by Andy Lundin | Dec 4, 2024 | Sepsis |
Our Lady of the Lake Ascension, a hospital in Louisiana, implemented Cytovale’s FDA-cleared IntelliSep sepsis detection technology.
Read MorePosted by Andy Lundin | Dec 3, 2024 | Lung Cancer, Molecular Diagnostics |
Studies validated Biofidelity’s Aspyre Lung diagnostic tech, showcasing its ability to offer genomic profiling for actionable NSCLC variants.
Read More